Gilead sciences, inc. (GILD)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Revenues:
Revenues

22,449

22,127

26,107

30,390

-

-

-

-

268

545

491

218

468

Total revenues

-

-

-

-

32,639

24,890

11,202

9,702

8,385

7,949

7,011

5,335

4,230

Costs and expenses:
Cost of goods sold

4,675

4,853

4,371

4,261

4,006

3,788

2,859

2,471

2,124

1,869

1,595

1,127

768

Research and development expenses

9,106

5,018

3,734

5,098

3,014

2,854

2,120

1,760

1,229

1,072

939

721

591

Selling, general and administrative expenses

4,381

4,056

3,878

3,398

3,426

2,983

1,699

1,461

1,241

1,044

946

797

705

Purchased in-process research and development

-

-

-

-

-

-

-

-

-

-

-

10

0

Total costs and expenses

18,162

13,927

11,983

12,757

10,446

9,625

6,678

5,692

4,595

3,987

3,482

2,657

2,065

Income from operations

4,287

8,200

14,124

17,633

22,193

15,265

4,524

4,010

3,789

3,962

3,529

2,678

2,164

Interest expense

995

1,077

1,118

964

688

412

307

361

205

108

69

65

63

Other income (expense), net

1,868

676

523

428

154

3

-9

-37

66

60

42

59

109

Income before provision for income taxes

5,160

7,799

13,529

17,097

21,659

14,856

4,208

3,612

3,651

3,913

3,501

2,672

2,211

Provision for income taxes

-204

2,339

8,885

3,609

3,553

2,797

1,151

1,038

861

1,023

876

702

635

Net income

5,364

5,460

4,644

13,488

18,106

12,059

3,057

2,574

2,789

2,889

2,625

1,970

1,575

Net loss attributable to noncontrolling interest

-22

5

16

-13

-2

-42

-18

-18

-14

-11

10

-8

-9

Net income attributable to Gilead

5,386

5,455

4,628

13,501

18,108

12,101

3,075

2,592

2,803

2,901

2,635

1,978

1,584

Net income per share attributable to Gilead common stockholders - basic (usd per share)

4.24

4.20

3.54

10.08

12.37

7.95

2.01

1.71

1.81

1.69

2.91

2.15

1.71

Shares used in per share calculation - basic (in shares)

1,270

1,298

1,307

1,339

1,464

1,522

1,529

1,515

1,549

1,712

904

920

929

Net income per share attributable to Gilead common stockholders - diluted (usd per share)

4.22

4.17

3.51

9.94

11.91

7.35

1.81

1.64

1.77

1.66

2.82

2.06

1.64

Shares used in per share calculation - diluted (in shares)

1,277

1,308

1,319

1,358

1,521

1,647

1,695

1,583

1,580

1,746

934

958

964

Cash dividends declared (usd per share)

-

-

-

-

1.29

0.00

0.00

-

-

-

-

-

-

Product sales
Revenues

22,119

21,677

25,662

29,953

32,151

24,474

10,804

9,398

8,102

7,389

6,469

5,084

3,733

Royalty, contract and other revenues
Revenues

330

450

445

437

488

416

398

304

14

13

50

32

28